| Lotus Eye Hospital & Institute Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 532998 |
NSE Symbol : LOTUSEYE |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE947I01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.04 |
|
Book Value(₹) : 28.92 |
Market Cap(₹Cr) : 280.54 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 13.61 | 13.55 | 13.04 | 13.52 | 11.51 | 12.25 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 13.61 | 13.55 | 13.04 | 13.52 | 11.51 | 12.25 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.48 | 0.24 | 0.27 | 0.19 | 0.52 | 0.22 |
| Total Income | 14.09 | 13.79 | 13.31 | 13.71 | 12.03 | 12.47 |
| Total Expenditure | 13.14 | 12.89 | 12.27 | 12.04 | 11.68 | 11.46 |
| PBIDT | 0.95 | 0.89 | 1.04 | 1.67 | 0.35 | 1.01 |
| Interest | 0.33 | 0.29 | 0.12 | 0.12 | 0.09 | 0.13 |
| PBDT | 0.62 | 0.61 | 0.92 | 1.55 | 0.26 | 0.88 |
| Depreciation | 1.10 | 0.98 | 0.85 | 0.82 | -0.58 | 1.31 |
| Tax | -0.07 | -0.06 | -0.01 | 0.14 | 0.13 | -0.10 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.09 | -0.05 | -0.04 | 0.04 | 0.46 | -0.09 |
| Reported Profit After Tax | -0.32 | -0.26 | 0.12 | 0.54 | 0.25 | -0.24 |
| Extra-ordinary Items | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.31 | -0.26 | 0.12 | 0.54 | 0.25 | -0.24 |
| EPS (Unit Curr.) | -0.15 | -0.13 | 0.06 | 0.26 | 0.12 | -0.11 |
| EPS (Adj) (Unit Curr.) | -0.15 | -0.13 | 0.06 | 0.26 | 0.12 | -0.11 |
| Calculated EPS (Unit Curr.) | -0.15 | -0.13 | 0.06 | 0.26 | 0.12 | -0.11 |
| Calculated EPS (Adj) (Unit Curr.) | -0.15 | -0.13 | 0.06 | 0.26 | 0.12 | -0.11 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.61 | -0.50 | 0.22 | 1.05 | 0.49 | -0.46 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.61 | -0.50 | 0.22 | 1.05 | 0.49 | -0.46 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.98 | 6.57 | 7.98 | 12.35 | 3.04 | 8.24 |
| PBDTM(%) | 4.56 | 4.50 | 7.06 | 11.46 | 2.26 | 7.18 |
| PATM(%) | -2.35 | -1.92 | 0.92 | 3.99 | 2.17 | -1.96 |
